Synthesis and antitumor activity of quaternary salts of 2-(2'- oxoalkoxy)-9-hydroxyellipticines

Chemical and Pharmaceutical Bulletin

Volumn 45, Issue 1, 1997, Pages 134-137

  Harada, Naoyuki ^a   Kawaguchi, Takayuki ^a   Inoue, Isao ^a   Ohashi, Motoaki ^a   Oda, Kouji ^a   Hashiyama, Tomiki ^a   Tsujihara, Kenji ^a  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

9 hydroxyellipticine 2 oxide; colon 26; Lewis lung carcinoma; P388 leukemia; water soluble

Indexed keywords

2 (3' METHOXY 2' OXOPROPANOXY) 9 HYDROXY 5,11 DIMETHYL 6H PYRIDO[4,3 B]CARBAZOLIUM BROMIDE; ANTINEOPLASTIC AGENT; ELLIPRAVIN; ELLIPTINIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; COLON CARCINOMA; CONTROLLED STUDY; DRUG POTENCY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; LEUKEMIA; LUNG CARCINOMA; MOUSE; NONHUMAN; STRUCTURE ACTIVITY RELATION;

EID: 0031022015     PISSN: 00092363     EISSN: None     Source Type: Journal    
DOI: 10.1248/cpb.45.134     Document Type: Article

References (10)

1. Dalton L. K., Demerac S., Elmes B. C., Loder J. W., Swan J. M., Aust. J. Chem., 20, 2715-2727 (1967).
2. Suffness M., "The Alkaloids," Vol. 25. Brossi A., (ed.), Academic Press, Inc., New York, 1985, pp. 89-304; Gribble G. W., ibid., 39, 307-352 (1990); Majima H., Niitani H., Taguchi T., Furue H., Abstracts of Papers, 15th International Cancer Congress, Hamburg, Germany, A4, A4-119-17, 1990.
3. Suffness M., "The Alkaloids," Vol. 25. Brossi A., (ed.), Academic Press, Inc., New York, 1985, pp. 89-304; Gribble G. W., ibid., 39, 307-352 (1990); Majima H., Niitani H., Taguchi T., Furue H., Abstracts of Papers, 15th International Cancer Congress, Hamburg, Germany, A4, A4-119-17, 1990.
4. Suffness M., "The Alkaloids," Vol. 25. Brossi A., (ed.), Academic Press, Inc., New York, 1985, pp. 89-304; Gribble G. W., ibid., 39, 307-352 (1990); Majima H., Niitani H., Taguchi T., Furue H., Abstracts of Papers, 15th International Cancer Congress, Hamburg, Germany, A4, A4-119-17, 1990.
5. Juret P., Tanguy A., Girard A., LeTalaer J. Y., Abbatucci J. S., Eur. J. Cancer, 14, 205-206 (1978).
6. Auclair C., Pierre A., Voisin E., Pepin O., Cros S., Colas C., Saucier J.-M., Verschuere B., Gros P., Paoletti C., Cancer Res., 47, 6254-6261 (1987).
7. Honda T., Kato M., Inoue M., Shimamoto T., Shima K., Nakanishi T., Yoshida T., Noguchi T., J. Med. Chem., 31, 1295-1305 (1988).
8. Guthrie R. W., Brossi A., Mennona F. A., Mullin J. G., Kierstead R. W., J. Med. Chem., 18, 755-760 (1975).
9. Rivalle C., Bisagni E., Heterocycles, 38, 391-397 (1994).
10. Crude 8 could not be purified by usual column chromatography on silica gel or by recrystallization, because it was hardly soluble in usual organic solvents.